• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Directories » Research Center Profiles » Einstein-Montefiore Institute for Clinical and Translational Research

AND
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • R
  • S
  • T
  • U
  • V
  • W

Einstein-Montefiore Institute for Clinical and Translational Research

  • Profile
  • Contact Center or Provider

Profile

Einstein-Montefiore Institute for Clinical and Translational Research

Contact Information

Phone: 718-430-2500
Email: Click here to see email.
Website: http://www.einstein.yu.edu/centers/ictr/clinical-trials

Center Information

Office of Clinical Trials
Einstein-Montefiore Institute for Clinical and Translational Research (ICTR)
Montefiore Medical Center (West Campus)
Moses Research Tower
111 E. 210 St., 8th Floor
Bronx, NY 10467
oct@montefiore.org
www.montefiore.org/clinicaltrials

Albert Einstein College of Medicine (East Campus)
1300 Morris Park Ave.
Block Bldg., 5th Floor
Bronx, NY 10461
718.430.2500
ICTR@einsteinmed.org
www.einstein.yu.edu/centers/ictr/clinical-trials

Currently Enrolling Trials

    Show More

    Overview

    The Albert Einstein College of Medicine is one of the nation’s premier institutions for medical education, basic research and clinical investigations. In September 2015, Montefiore Health System assumed full operational control of Einstein. Together, Einstein-Montefiore advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Combining nationally recognized clinical excellence with a population health perspective that focuses on the comprehensive needs of the communities it serves, Einstein-Montefiore delivers coordinated, compassionate, science-driven care where, when and how patients need it most. Montefiore Health System is comprised of more than 2,400 providers and spans 11 hospitals, including the Children's Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The health system derives its inspiration for excellence from its patients and community and continues to be on the front lines of developing innovative approaches to care.

    While education is at the heart of Einstein’s mission, it is biomedical research that drives the College of Medicine’s growth. Einstein’s relationship with Montefiore supports a long-standing focus on bench-to-bedside research, through which discoveries in Einstein’s laboratories lead to therapies and treatments for patients on an accelerated timetable.

    Long a national leader in biomedical research support from the federal government, Albert Einstein College of Medicine secured $197.3 million from the National Institutes of Health in federal fiscal year 2020 — the largest annual total in Einstein’s history. Factoring in the grants to Montefiore Health System, Einstein’s University Hospital and academic medical center and additional contracts, the total tips $223.6 million, reflecting a notable expansion of Einstein-Montefiore’s research enterprise. This includes the funding for Einstein major research centers in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease and AIDS. Other areas of focus include developmental brain research, neuroscience, cardiac disease and initiatives to reduce and eliminate ethnic and racial health disparities.

    Einstein also was the only New York City institution selected to participate in the federal government’s landmark Women’s Health Initiative, and it is currently one of just four sites nationwide taking part in a large-scale study of the health status of the Hispanic/Latino community in the Bronx, supported by the NIH. The following are NIH Designated Centers:

    • Albert Einstein Cancer Center
    • Center for Aids Research
    • Diabetes Research Center
    • Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore
    • Institute for Aging Research
    • Marion Bessin Liver Research Center
    • New York Regional Center for Diabetes Translation Research
    • Rose F. Kennedy Intellectual and Developmental Disabilities Research Center

    The Einstein-Montefiore collaboration includes four jointly run Centers of Excellence and is further strengthened by the dual appointments of faculty and physicians across both institutions, enhancing synergies in research, teaching and patient care. The Montefiore-Einstein Centers of Excellence are:

    • Children’s Hospital at Montefiore (CHAM)
    • Montefiore-Einstein Center for Cancer Care
    • Montefiore-Einstein Center for Heart and Vascular Care
    • Montefiore-Einstein Center for Transplantation

    Research Experience

    Einstein-Montefiore Research and Treatment Milestones

    • Montefiore was among the first hospitals to establish departments of social services (1914), home healthcare (1947) and social medicine (1950).
    • In 1994, it became the only New York City medical school selected by the NIH to participate in the Women's Health Treatment Initiative, the largest research study of women's health ever.
    • The state-of-the-art Children's Hospital at Montefiore (CHAM) opened in 2001 and quickly in 2004 earned a world-class reputation for pediatric care with our successful separation of twins conjoined at the head.
    • In 2006, it was the only medical institution in the northeast to serve as a research site for the Hispanic Community Health Study, the largest research study of Hispanic health ever.
    • Leader of the Bronx Regional Health Information Organization (Bronx RHIO), a Bronx-wide consortium intended to facilitate clinical information exchange. The purpose is to build a secure, interoperable health information exchange that will promote patient-centered, rational, cost-effective treatments throughout the system.
    • In 2019, the Albert Einstein College of Medicine in partnership with NYU School of Medicine received a grant from the NIH to establish the Early Phase Pain Investigation Clinical Network (EPICC-Net): Greater New York Clinical Center. EPICC-Net seeks to enhance the treatment of acute and chronic pain and reduce reliance on opioids by accelerating early-phase clinical trials of nonaddictive treatments for pain.
    • Demonstrated the association between reduced levels of high-density lipoproteins (HDL) or "good" cholesterol, and heart disease.
    • Helped to develop ground-breaking new protocols for the treatment of diabetes based on more sophisticated methods of monitoring glucose levels.
    • Developed pioneering techniques, including three types of regional chemotherapy treatments, for the diagnosis and treatment of cancer based on the genetics of both the tumor and the patient.
    • Developed treatments and technology that revolutionized medical care, such as the cardiac pacemaker and cardiac catherization, now used worldwide.
    • In 2011, Montefiore was recognized by the Centers for Medicare & Medicaid Services as a Pioneer Accountable Care Organization for the formation of highly integrated teams of health professionals managing care around the patient, focusing on communication, coordination, engagement and prevention to provide higher quality care while reducing costs.
    • In 2019, Montefiore Medical Center was ranked number six in New York and nationally as ninth in adult specialties and sixth in children’s specialties, according to U.S. News & World Report.  The hospital is rated high-performing in one adult specialty (orthopedics) and four adult procedures and conditions, including chronic obstructive pulmonary disease, colon cancer surgery, heart failure and knee replacement.

    Treatment Areas

    • Acute and Chronic Pain
    • Aging
    • Asthma
    • Atrial Fibrillation
    • Autism
    • Cancer
    • Congestive Heart Failure
    • Contraception
    • Dementia
    • Depression
    • Diabetes
    • Eczema
    • Genetic Diseases
    • Headache/Migraine
    • Healthy Volunteers
    • Heart Disease
    • Hidradenitis Suppurativa
    • Infectious Diseases
    • Inflammatory Bowel Disease
    • Joint Diseases
    • Kidney Disease
    • Learning & Developmental Disabilities
    • Liver Disease
    • Lung Disease
    • Lupus
    • Obesity
    • Obsessive Compulsive Disorder
    • Opioid Use Disorder
    • Psoriasis
    • Respiratory Disease
    • Sepsis
    • Sexually Transmitted Diseases
    • Sickle Cell Disease
    • Sleep & Wake Disorders
    • Substance Abuse and Addiction
    • Transplantation

    Investigator Experience

    Albert Einstein College of Medicine is comprised of 2,153 faculty members with international recognition and known as prominent leaders in their respective fields. These outstanding physicians and scientists are responsible for unparalleled scientific innovation and first-class application of medicine, having published 3,292 papers in peer-reviewed journals in 2018.

    Staff Expertise

    The research staff has extensive experience in conducting clinical research projects, including but not limited to study coordination, data management, human subject protection, study monitoring, contract negotiation, budget development, regulatory oversight, clinical project management, database development, data and safety monitoring community engagement and regulatory affairs.

    Other Information

    Founded on the partnership between Albert Einstein College of Medicine and Montefiore Medical Center, the ICTR has helped cement collaboration in clinical and translation research since 2007. The ICTR is a member of the nationwide Clinical and Translational Science Awards (CTSA) consortium, funded by the NIH. The CTSA is designed to break down barriers that inhibit cross-disciplinary, bidirectional research from the laboratory to the clinic and back again.

    The mission of the Einstein-Montefiore ICTR is to

    • Improve the transfer of information from "bench-to-bedside” to better serve the community;
    • Enhance community participation in research activities;
    • Enhance the discipline of clinical and translational research by promoting multidisciplinary collaboration;
    • Address critical barriers in research to accelerate the transition of beneficial research;
    • Provide infrastructure and collaborative support; and
    • Enhance training, education and career development as part of the CTSA consortium in order to improve opportunities for the development of a diverse investigator and research community.

    Contact Center or Provider

    Back to Listings

    Upcoming Events

    • 16Feb

      Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

    • 21May

      WCG MAGI Clinical Research Conference – 2023 East

    Featured Products

    • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

      Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    Featured Stories

    • SurveywBlueBackground-360x240.png

      Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

    • TrendsInsights2023-360x240.png

      WCG Clinical Research Trends and Insights for 2023, Part Two

    • TimeMoneyEffort-360x240.png

      Time is Money and So Is Effort, Budgeting Experts Say

    • TrendsInsights2023A-360x240.png

      WCG Clinical Research Trends and Insights for 2023, Part Three

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 617.948.5100 – Toll free 866.219.3440

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing